Cause-specific Mortality Risk in Alcohol Use Disorder Treatment Patients: a Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Background: Alcohol use disorders (AUD) are highly disabling. Recent studies reported much higher relative risks for all-cause mortality in AUD patients compared with earlier studies. Systematic evidence regarding cause-specific mortality among AUD patients has been unavailable to date.
Methods: Studies were identified through MEDLINE, EMBASE and Web of Science up to August 2012. Following MOOSE guidelines, prospective and historical cohort studies assessing cause-specific mortality risk from AUD patients at baseline compared with the general population were selected. Data on several study characteristics, including AUD assessment, follow-up period, setting, location and cause-specific mortality risk compared with the general population were abstracted. Random-effect meta-analyses were conducted.
Results: Overall, 17 observational studies with 6420 observed deaths among 28 087 AUD patients were included. Pooled standardized mortality ratios (SMRs) after 10 years of follow-up among men were 14.8 (95% confidence interval: 8.7-24.9) for liver cirrhosis, 18.0 (11.2-30.3) for mental disorders, 6.6 (5.0-8.8) for death by injury and around 2 for cancer and cardiovascular diseases. SMRs were substantially higher in women, with fewer studies available. For many outcomes the risk has been increasing substantially over time.
Conclusions: Cause-specific mortality among AUD patients was high in all major categories compared with the general population. There has been a lack of recent research, and future studies should focus on the influence of comorbidities on excess mortality risk among AUD patients. Efforts to reduce these risks should be a priority, given that successful treatment reduces mortality risk substantially for a relatively common psychiatric disease.
Alcohol and cause-specific mortality in Russia: the Know Your Heart Study 2015-23.
Mitkin N, Brenn T, Unguryanu T, Malyutina S, Cook S, Kudryavtsev A BMC Public Health. 2024; 24(1):3128.
PMID: 39533329 PMC: 11555830. DOI: 10.1186/s12889-024-20674-8.
Georgescu O, Martin L, Tartea G, Rotaru-Zavaleanu A, Dinescu S, Vasile R Life (Basel). 2024; 14(9).
PMID: 39337917 PMC: 11433171. DOI: 10.3390/life14091134.
Snapshot of knowledge and stigma toward mental health disorders and treatment in Spain.
Varaona A, Molina-Ruiz R, Gutierrez-Rojas L, Perez-Paramo M, Lahera G, Donat-Vargas C Front Psychol. 2024; 15:1372955.
PMID: 39282679 PMC: 11397762. DOI: 10.3389/fpsyg.2024.1372955.
Lange S, Zhu Y, Probst C Inj Prev. 2024; .
PMID: 39053921 PMC: 11757798. DOI: 10.1136/ip-2023-045182.
Grote V, Wagner T, Riedl D, Kautzky-Willer A, Fischer M, Scheibenbogen O Subst Abuse Rehabil. 2024; 15:31-42.
PMID: 38567036 PMC: 10986415. DOI: 10.2147/SAR.S454436.